RECRUITING

Emotional Awareness and Expression Therapy for Chronic Pain and Opioid Use Disorder

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The study is intended to test whether a group-based Zoom behavioral treatment can help adults with chronic pain and opioid use disorder (OUD) learn effective strategies for reducing pain, disability and other problems that can come with these conditions (such as depression, anxiety, and difficulty managing emotions).

Official Title

Emotional Awareness and Expression Therapy for Chronic Pain and Opioid Use Disorder - A Pilot Study

Quick Facts

Study Start:2025-06
Study Completion:2026-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06865560

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Be able to read, write and speak English
  2. * Have Internet access and audio-visual conferencing capability (e.g., Zoom meetings by phone or computer) in the home
  3. * Widespread pain and has opioid use disorder (OUD)
  1. * Diagnosis of autoimmune disease, spinal cord injury, cancer.
  2. * Currently receiving cognitive-behavioral therapy, EAET, or other psychological therapies for pain
  3. * Open litigation regarding chronic pain in the past 1 year, as assessed in preliminary study screening.
  4. * Inability to provide informed consent and complete study procedures (e.g., indications of suspected major cognitive impairment via observations of study staff during consenting) that would preclude comprehension or participation in study protocols.
  5. * Pregnant or breastfeeding
  6. * Any other diseases or conditions that would make a patient unsuitable for study participation as determined by the site principal investigators.

Contacts and Locations

Study Contact

Joseph Long
CONTACT
734-763-0108
josephlo@med.umich.edu
Sana Shaikh
CONTACT
734-763-5226
skazi@med.umich.edu

Principal Investigator

John Sturgeon, PhD
PRINCIPAL_INVESTIGATOR
University of Michigan

Study Locations (Sites)

The University of Michigan
Ann Arbor, Michigan, 48109
United States

Collaborators and Investigators

Sponsor: University of Michigan

  • John Sturgeon, PhD, PRINCIPAL_INVESTIGATOR, University of Michigan

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-06
Study Completion Date2026-01

Study Record Updates

Study Start Date2025-06
Study Completion Date2026-01

Terms related to this study

Additional Relevant MeSH Terms

  • Chronic Pain
  • Opioid Use Disorder